Polycystins, focal adhesions and extracellular matrix interactions

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 10, 2011, Pages 1322-1326

  Drummond, Iain A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Autosomal dominant; Extracellular matrix; Focal adhesion; Mechanosensory; Polycystic kidney disease; Polycystin

Indexed keywords

ALPHA ACTININ; CRK ASSOCIATED SUBSTRATE PROTEIN; LAMININ; PAXILLIN; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN KINASE P60; TALIN; TENSIN; VINCULIN;

ANEURYSM; AORTA ANEURYSM; AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; BINDING SITE; CALCIUM TRANSPORT; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FOCAL ADHESION; GASTROINTESTINAL DISEASE; GENE EXPRESSION; HUMAN; IMMUNOLOCALIZATION; INTRACRANIAL ANEURYSM; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MUSCLE CONTRACTION; PERICARDIAL EFFUSION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VALVULAR HEART DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FOCAL ADHESIONS; HUMANS; KIDNEY; MECHANOTRANSDUCTION, CELLULAR; MICE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; SIGNAL TRANSDUCTION; TRPP CATION CHANNELS;

EID: 80052270877     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.003     Document Type: Review

References (82)

1. Harris P.C., Torres V.E. Polycystic kidney disease. Annu. Rev. Med. 2009, 60:321-337.
2. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
3. Sutters M., Germino G.G. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J. Lab. Clin. Med. 2003, 141:91-101.
4. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E., Lu W., Brown E.M., Quinn S.J., Ingber D.E., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
5. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., Ehrlich B.E., Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 2002, 4:191-197.
6. Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K., San Millan J.L., Gamble V., Harris P.C. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 1995, 10:151-160.
7. Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B., Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A., Kimberling W.J., Breuning M.H., Deltas C.C., Peters D.J., Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272:1339-1342.
8. Yoder B.K. Role of primary cilia in the pathogenesis of polycystic kidney disease. J. Am. Soc. Nephrol. 2007, 18:1381-1388.
9. Davenport J.R., Watts A.J., Roper V.C., Croyle M.J., van Groen T., Wyss J.M., Nagy T.R., Kesterson R.A., Yoder B.K. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 2007, 17:1586-1594.
10. Takakura A., Contrino L., Beck A.W., Zhou J. Pkd1 inactivation induced in adulthood produces focal cystic disease. J. Am. Soc. Nephrol. 2008, 19:2351-2363.
11. Patel V., Li L., Cobo-Stark P., Shao X., Somlo S., Lin F., Igarashi P. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 2008, 17:1578-1590.
12. Natoli T.A., Gareski T.C., Dackowski W.R., Smith L., Bukanov N.O., Russo R.J., Husson H., Matthews D., Piepenhagen P., Ibraghimov-Beskrovnaya O. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am. J. Physiol. Ren. Physiol. 2008, 294:F73-F83.
13. Lin F., Hiesberger T., Cordes K., Sinclair A.M., Goldstein L.S., Somlo S., Igarashi P. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5286-5291.
14. Shibazaki S., Yu Z., Nishio S., Tian X., Thomson R.B., Mitobe M., Louvi A., Velazquez H., Ishibe S., Cantley L.G., Igarashi P., Somlo S. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum. Mol. Genet. 2008, 17:1505-1516.
15. Wilson P.D., Hreniuk D., Gabow P.A. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J. Cell. Physiol. 1992, 150:360-369.
16. Cuppage F.E., Huseman R.A., Chapman A., Grantham J.J. Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int. 1980, 17:372-381.
17. Candiano G., Gusmano R., Altieri P., Bertelli R., Ginevri F., Coviello D.A., Sessa A., Caridi G., Ghiggeri G.M. Extracellular matrix formation by epithelial cells from human polycystic kidney cysts in culture. Virchows Arch. B., Cell Pathol. 1992, 63:1-9.
18. Mangos S., Lam P.Y., Zhao A., Liu Y., Mudumana S., Vasilyev A., Liu A., Drummond I.A. The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation. Dis Model Mech 2010, 3:354-365.
19. Schafer K., Bader M., Gretz N., Oberbaumer I., Bachmann S. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease. Exp. Nephrol. 1994, 2:190-195.
20. Ebihara I., Nakamura T., Takahashi T., Yamamoto M., Tomino Y., Nagao S., Takahashi H., Koide H. Altered extracellular matrix component gene expression in murine polycystic kidney. Renal Physiol. Biochem. 1995, 18:73-80.
21. Wilson P.D., Geng L., Li X., Burrow C.R. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab. Invest. 1999, 79:1311-1323.
22. Wilson P.D. Polycystic kidney disease. N. Engl. J. Med. 2004, 350:151-164.
23. Joly D., Morel V., Hummel A., Ruello A., Nusbaum P., Patey N., Noel L.H., Rousselle P., Knebelmann B. Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am. J. Pathol. 2003, 163:1791-1800.
24. Husson H., Manavalan P., Akmaev V.R., Russo R.J., Cook B., Richards B., Barberio D., Liu D., Cao X., Landes G.M., Wang C.J., Roberts B.L., Klinger K.W., Grubman S.A., Jefferson D.M., Ibraghimov-Beskrovnaya O. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics 2004, 84:497-510.
25. Lee J.E., Park M.H., Park J.H. The gene expression profile of cyst epithelial cells in autosomal dominant polycystic kidney disease patients. J. Biochem. Mol. Biol. 2004, 37:612-617.
26. Riera M., Burtey S., Fontes M. Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism. Kidney Int. 2006, 69:1558-1563.
27. Koupepidou P., Felekkis K.N., Kranzlin B., Sticht C., Gretz N., Deltas C. Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways. BMC Nephrol. 2010, 11:23.
28. Shannon M.B., Patton B.L., Harvey S.J., Miner J.H. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J. Am. Soc. Nephrol. 2006, 17:1913-1922.
29. Lo S.H., Yu Q.C., Degenstein L., Chen L.B., Fuchs E. Progressive kidney degeneration in mice lacking tensin. J. Cell Biol. 1997, 136:1349-1361.
30. Quinlan M.R., Docherty N.G., Watson R.W., Fitzpatrick J.M. Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction. Am. J. Physiol. Renal Physiol. 2008, 295:F1-F11.
31. Martinez J.R., Grantham J.J. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis. Mon. 1995, 41:693-765.
32. Biagini A., Maffei S., Baroni M., Piacenti M., Terrazzi M., Paoli F., Trianni G., Picano E., Salvatore L. Familiar clustering of aortic dissection in polycystic kidney disease. Am. J. Cardiol. 1993, 72:741-742.
33. van Dijk M.A., Chang P.C., Peters D.J., Breuning M.H. Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. J. Am. Soc. Nephrol. 1995, 6:1670-1673.
34. Gibbs G.F., Huston J., Qian Q., Kubly V., Harris P.C., Brown R.D., Torres V.E. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int. 2004, 65:1621-1627.
35. Zhang B., Fugleholm K., Day L.B., Ye S., Weller R.O., Day I.N. Molecular pathogenesis of subarachnoid haemorrhage. Int. J. Biochem. Cell Biol. 2003, 35:1341-1360.
36. El-Hamamsy I., Yacoub M.H. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat. Rev. Cardiol. 2009, 6:771-786.
37. Hassane S., Claij N., Lantinga-van Leeuwen I.S., Van Munsteren J.C., Van Lent N., Hanemaaijer R., Breuning M.H., Peters D.J., DeRuiter M.C. Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2177-2183.
38. Kim K., Drummond I., Ibraghimov-Beskrovnaya O., Klinger K., Arnaout M.A. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1731-1736.
39. Ebihara I., Killen P.D., Laurie G.W., Huang T., Yamada Y., Martin G.R., Brown K.S. Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease. Lab. Invest. 1988, 58:262-269.
40. Sharif-Naeini R., Folgering J.H., Bichet D., Duprat F., Lauritzen I., Arhatte M., Jodar M., Dedman A., Chatelain F.C., Schulte U., Retailleau K., Loufrani L., Patel A., Sachs F., Delmas P., Peters D.J., Honore E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 2009, 139:587-596.
41. Voets T., Nilius B. TRPCs, GPCRs Bayliss effect. Embo J. 2009, 28:4-5.
42. Morel N., Vandenberg G., Ahrabi A.K., Caron N., Desjardins F., Balligand J.L., Horie S., Devuyst O. PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflugers Arch. 2008.
43. Haga J.H., Li Y.S., Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J. Biomech. 2007, 40:947-960.
44. Morris-Stiff G., Coles G., Moore R., Jurewicz A., Lord R. Abdominal wall hernia in autosomal dominant polycystic kidney disease. Br. J. Surg. 1997, 84:615-617.
45. Henriksen N.A., Yadete D.H., Sorensen L.T., Agren M.S., Jorgensen L.N. Connective tissue alteration in abdominal wall hernia. Br. J. Surg. 2010.
46. Qian Q., Hartman R.P., King B.F., Torres V.E. Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 2007, 2:1223-1227.
47. Hossack K.F., Leddy C.L., Johnson A.M., Schrier R.W., Gabow P.A. Echocardiographic findings in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 1988, 319:907-912.
48. Arnaout M.A., Mahalingam B., Xiong J.P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 2005, 21:381-410.
49. Scheffers M.S., van der Bent P., Prins F., Spruit L., Breuning M.H., Litvinov S.V., de Heer E., Peters D.J. Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum. Mol. Genet. 2000, 9:2743-2750.
50. Xu G.M., Sikaneta T., Sullivan B.M., Zhang Q., Andreucci M., Stehle T., Drummond I., Arnaout M.A. Polycystin-1 interacts with intermediate filaments. J. Biol. Chem. 2001, 276:46544-46552.
51. Grimm D.H., Cai Y., Chauvet V., Rajendran V., Zeltner R., Geng L., Avner E.D., Sweeney W., Somlo S., Caplan M.J. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J. Biol. Chem. 2003, 278:36786-36793.
52. Qian Q., Li M., Cai Y., Ward C.J., Somlo S., Harris P.C., Torres V.E. Analysis of the polycystins in aortic vascular smooth muscle cells. J. Am. Soc. Nephrol. 2003, 14:2280-2287.
53. Wozniak M.A., Modzelewska K., Kwong L., Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 2004, 1692:103-119.
54. Giannone G., Sheetz M.P. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol. 2006, 16:213-223.
55. Hayakawa K., Tatsumi H., Sokabe M. Actin stress fibers transmit and focus force to activate mechanosensitive channels. J. Cell Sci. 2008, 121:496-503.
56. Wilson P.D., Burrow C.R. Cystic diseases of the kidney: role of adhesion molecules in normal and abnormal tubulogenesis. Exp. Nephrol. 1999, 7:114-124.
57. Geng L., Burrow C.R., Li H.P., Wilson P.D. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim. Biophys. Acta 2000, 1535:21-35.
58. Joly D., Ishibe S., Nickel C., Yu Z., Somlo S., Cantley L.G. The polycystin 1-C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells. J. Biol. Chem. 2006, 281:26329-26339.
59. Malhas A.N., Abuknesha R.A., Price R.G. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J. Am. Soc. Nephrol. 2002, 13:19-26.
60. Drickamer K., Taylor M.E. Biology of animal lectins. Annu. Rev. Cell Biol. 1993, 9:237-264.
61. Weston B.S., Bagneris C., Price R.G., Stirling J.L. The polycystin-1C-type lectin domain binds carbohydrate in a calcium-dependent manner, and interacts with extracellular matrix proteins in vitro. Biochim. Biophys. Acta 2001, 1536:161-176.
62. Bycroft M., Bateman A., Clarke J., Hamill S.J., Sandford R., Thomas R.L., Chothia C. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J. 1999, 18:297-305.
63. Zhao G.Y., Chen X.L., Zhao H.L., Xie B.B., Zhou B.C., Zhang Y.Z. Hydrolysis of insoluble collagen by deseasin MCP-01 from deep-sea Pseudoalteromonas sp. SM9913: collagenolytic characters, collagen-binding ability of C-terminal polycystic kidney disease domain, and implication for its novel role in deep-sea sedimentary particulate organic nitrogen degradation. J. Biol. Chem. 2008, 283:36100-36107.
64. Wang Y.K., Zhao G.Y., Li Y., Chen X.L., Xie B.B., Su H.N., Lv Y.H., He H.L., Liu H., Hu J., Zhou B.C., Zhang Y.Z. Mechanistic insight into the function of the C-terminal PKD domain of the collagenolytic serine protease deseasin MCP-01 from deep sea Pseudoalteromonas sp. SM9913: binding of the PKD domain to collagen results in collagen swelling but does not unwind the collagen triple helix. J. Biol. Chem. 2010, 285:14285-14291.
65. Vogel V. Mechanotransduction involving multimodular proteins: converting force into biochemical signals. Annu. Rev. Biophys. Biomol. Struct. 2006, 35:459-488.
66. Baneyx G., Baugh L., Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:5139-5143.
67. Sawada Y., Tamada M., Dubin-Thaler B.J., Cherniavskaya O., Sakai R., Tanaka S., Sheetz M.P. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 2006, 127:1015-1026.
68. Qian F., Wei W., Germino G., Oberhauser A. The nanomechanics of polycystin-1 extracellular region. J. Biol. Chem. 2005, 280:40723-40730.
69. Forman J.R., Qamar S., Paci E., Sandford R.N., Clarke J. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J. Mol. Biol. 2005, 349:861-871.
70. Ma L., Xu M., Forman J.R., Clarke J., Oberhauser A.F. Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains. J. Biol. Chem. 2009, 284:32942-32949.
71. Ma L., Xu M., Oberhauser A.F. Naturally occurring osmolytes modulate the nanomechanical properties of polycystic kidney disease domains. J. Biol. Chem. 2010, 285:38438-38443.
72. Wei W., Hackmann K., Xu H., Germino G., Qian F. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J. Biol. Chem. 2007, 282:21729-21737.
73. Wozniak M.A., Chen C.S. Mechanotransduction in development: a growing role for contractility. Nat. Rev. Mol. Cell Biol. 2009, 10:34-43.
74. Kim T.J., Seong J., Ouyang M., Sun J., Lu S., Hong J.P., Wang N., Wang Y. Substrate rigidity regulates Ca2+ oscillation via RhoA pathway in stem cells. J. Cell. Physiol. 2009, 218:285-293.
75. Wei W.C., Hsu Y.C., Chiu W.T., Wang C.Z., Wu C.M., Wang Y.K., Shen M.R., Tang M.J. Low substratum rigidity of collagen gel promotes ERK phosphorylation via lipid raft to augment cell migration. J. Cell. Biochem. 2008, 103:1111-1124.
76. Guo W.H., Frey M.T., Burnham N.A., Wang Y.L. Substrate rigidity regulates the formation and maintenance of tissues. Biophys. J. 2006, 90:2213-2220.
77. Wang Y.K., Wang Y.H., Wang C.Z., Sung J.M., Chiu W.T., Lin S.H., Chang Y.H., Tang M.J. Rigidity of collagen fibrils controls collagen gel-induced down-regulation of focal adhesion complex proteins mediated by alpha2beta1 integrin. J. Biol. Chem. 2003, 278:21886-21892.
78. Lo C.M., Wang H.B., Dembo M., Wang Y.L. Cell movement is guided by the rigidity of the substrate. Biophys. J. 2000, 79:144-152.
79. Wozniak M.A., Desai R., Solski P.A., Der C.J., Keely P.J. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 2003, 163:583-595.
80. Wallace D.P., Quante M.T., Reif G.A., Nivens E., Ahmed F., Hempson S.J., Blanco G., Yamaguchi T. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am. J. Physiol. Renal Physiol. 2008, 295:F1463-F1471.
81. Haverty T.P., Neilson E.G. Basement membrane gene expression in polycystic kidney disease. Lab. Invest. 1988, 58:245-248.
82. Bissler J.J., Dixon B.P. A mechanistic approach to inherited polycystic kidney disease. Pediatr. Nephrol. 2005, 20:558-566.